Borsa İstanbul Dividend Wave: August-September Cash Flows and Market Depth
724FinanceVolkan Şen
Key Highlights
Borsa İstanbul’da yaklaşan nakit temettü dönemi, piyasa derinliğini test edecek ve sermaye akışlarını belirgin şekilde şekillendirecek kritik bir liki

Borsa İstanbul is entering a critical liquidity cycle for August and September, as scheduled cash dividend payments are set to test market depth and significantly reshape capital flows.
Dividend Calendar and Portfolio Rebalancing
In this period where investment strategies are reconfigured, the timing of dividend payments creates a natural correction mechanism in equity pricing, while volume changes in broker distributions (AKD) dictate the route of "smart money."Smart Money and Dark Pool Activity
While retail investors focus on the cash dividend, HFT algorithms and dark pool operations take positions in seconds to convert the dividend selling pressure into arbitrage opportunities.As Volkan Şen, analyzing market depth, I observe that abnormal accumulations in broker distribution data during dividend announcement periods signal not just cash collection, but also short-term short covering scenarios. Smart money adjusts its position in advance, anticipating the post-dividend price drop, and circulates large volumes in dark pools to minimize market impact.
Related News & Analysis
View All →
Europe's Energy Market Winter Storm: Gas and Diesel Bottleneck

HSBC's BIST 100 Power Plays

Market Liquidity Leaders: Dominance of Top Brokerage Firms in Trading Volume

Trump's Midterm Forecast and the Balance of Power in Washington

Turkish Airlines Reinforces Global Stance with Record July Traffic

Revival in German Industry: Signal Reshaping Global Risk Appetite
Latest Market News
All News →
Europe's Energy Market Winter Storm: Gas and Diesel Bottleneck
THY Hits Record Passenger Numbers and Load Factor in July

Fed’s Silence Ignites Bonds: A Boon for Retirees, a Burden for Homebuyers
Kyndryl Q1 2027 Results: AI-Driven Growth and Workforce Rebalancing Impact Markets
Sarepta Therapeutics'in 2026 Q2 Kazanç Çağrısı: SiRNA Platformu ve ELEVIDYS Gelir Tahmini
